No … no “isolationists” are recorded in the “postive” figures.
https://coronavirus.data.gov.uk/details/cases?areaType=overview&areaName=United%20Kingdom
No … no “isolationists” are recorded in the “postive” figures.
https://coronavirus.data.gov.uk/details/cases?areaType=overview&areaName=United%20Kingdom
Cases
People tested positive
Latest data provided on 4 November 2021
Daily
37,269
Last 7 days
275,264
Down to high …
Cases
People tested positive
Latest data provided on 5 November 2021
Daily
34,029
Last 7 days
265,826
Staying down at high …
The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.
The tablet - molnupiravir - will be given twice a day to vulnerable patients recently diagnosed with the disease.
In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half.
Health Secretary Sajid Javid said the treatment was a “gamechanger” for the most frail and immunosuppressed.
In a statement he said: “Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for Covid.”
First oral treatment
Molnupiravir, developed by the US drug companies Merck, Sharp and Dohme (MSD) and Ridgeback Biotherapeutics, is the first antiviral medication for Covid which can be taken as a pill rather than injected or given intravenously.
The UK has agreed to purchase 480,000 courses with the first deliveries expected in November.
Initially it will be given to both vaccinated and unvaccinated patients through a national study, with extra data on its effectiveness collected before any decision to order more.
An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug - Paxlovid - is intended for use soon after symptoms develop in people at high risk of severe disease.
It comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Pfizer says it stopped trials early as the initial results were so positive.
The UK has already ordered 250,000 courses of the new Pfizer treatment, along with another 480,000 courses of MSD’s molnupiravir pill.
Health and Social Care Secretary Sajid Javid called the results “incredible”, and said the UK’s medicines regulator would now assess its safety and effectiveness.
“If approved, this could be another significant weapon in our armoury to fight the virus alongside our vaccines and other treatments,” he said.
The Pfizer drug, known as a protease inhibitor, is designed to block an enzyme the virus needs in order to multiply. When taken alongside a low dose of another antiviral pill called ritonavir, it stays in the body for longer.
Three pills are taken twice a day for five days.
The combination treatment works slightly differently to the Merck pill, which introduces errors into the genetic code of the virus.
Blimey … TWO excellent advances in COVID treatment …
Cases
People tested positive
Latest data provided on 6 November 2021
Daily
30,693
Last 7 days
255,241
Only just high …
8 November 2021
Because of network issues, today’s update is delayed
Cases
People tested positive
Latest data provided on 8 November 2021
Daily
32,322
Last 7 days
239,782
Back to very high …
Cases
People tested positive
Latest data provided on 9 November 2021
Daily
33,117
Last 7 days
239,034
Staying very high (but at the low end) …
Cases
People tested positive
Latest data provided on 10 November 2021
Daily
39,329
Last 7 days
237,064
Staying very high (at the high end) …
Cases
People tested positive
Latest data provided on 11 November 2021
Daily
42,408
Last 7 days
242,203
Very high (at the low end) …
Cases
People tested positive
Latest data provided on 12 November 2021
Daily
40,375
Last 7 days
248,549
Very high (at the low end) …
While many European countries are seeing steep rises in coronavirus cases and preparing to step up Covid restrictions, the UK has been going in the other direction. Until recently, the UK had been seeing the highest rates of cases and deaths in Europe. In recent weeks these have been falling in Britain.
Prime Minister Boris Johnson said the wave of infections sweeping across Europe was a reminder that the pandemic had not gone away and there was no room for complacency.
The latest daily figure for the number of people testing positive in the UK is 40,375. This week has seen 7% fewer cases than the week before. The UK figures have - like a cruising aeroplane dealing with turbulence - been bouncing around roughly the same level since the summer.
Covid cases are now taking off in large swathes of Europe, with some countries already climbing to a higher altitude than the UK. If you look at the rate per million people, around 500 would test positive for Covid each day in the UK. In Austria the figure is more than double this.
The Netherlands, which has also overtaken the UK, is about to declare three weeks of restrictions in Western Europe’s first “partial lockdown” of winter.
Similar countries such as Germany are marginally lower, but the trajectory is causing concern and led to warnings of 100,000 deaths in the country this week.
It ain’t over 'til it’s over …
Cases
People tested positive
Latest data provided on 13 November 2021
Daily
38,351
Last 7 days
256,207
The usual weekend fall …
Cases
People tested positive
People tested positive
Latest data provided on 14 November 2021
Daily
36,517
Last 7 days
262,419
The usual weekend fall …
Cases
People tested positive
Latest data provided on 15 November 2021
Daily
39,705
Last 7 days
269,802
The usual Monday rise …
Thank You …
Cases
People tested positive
Latest data provided on 16 November 2021
Daily
37,243
Last 7 days
273,928
Falling back to high …
Cases
People tested positive
Latest data provided on 17 November 2021
Daily
38,263
Last 7 days
272,862
Staying high …